Kommanaboyina B,Rhodes CT .1999 .Trends in stability testing, with emphasis on stability during distribution and storage. Drug Dev Ind Pharm, 25(7) : 857-68.
Lindholm J. Development .2004 .and validation of HPLC methods for analytical and preparative purposes. Acta Universitatis Upsaliensis, 13 : 1-23.
Blessy M,Patel RD,Prajapati PN,Agrawal YK .2014 .Development of forced degradation and stability indicating studies of drugs-A review. J Pharm Anal, 4(3) : 159-65.
Thiruvengadam D,Vasanth PM,Kumar P. A Stability-Indicating RP .2011 .HPLC Method for the Determination of Related Substances in Drug Substances and Drug Products. Chromatographia, 74 : 893-902.
Hu M,Tomita M,Hayashi T,Awazu S. .1998 .Simultaneous determination of related substances of irinotecan hydrochloride by reversed-phase ion-pair high-performance liquid chromatography. J Chromatogr A, 828(1-2) : 373-80.
ICH .2006 .Q3A (R2). Impurities in New Drug Substances. ICH Harmonized Tripartite Guideline, : .
Swartz ME,Krull IS .2012 .Analytical Method Development and Validation. , : .
Zambon S,Ellison SL,Williams A .2012 .Validation of a high-performance liquid chromatography method for related substances in a pharmaceutical drug substance. J Chromatogr A, 1257 : 181-9.
Chan CC,Lee YC,Lam H,Zhang XM .2004 .Analytical Method Validation and Instrument Performance Verification. , : .
Huynh-Ba K,Practices Best .2009 .. , : .
Kunimoto R,Harada M,Sugino T,Kuribayashi T. .2021 .Application of Quality by Design (QbD) to enhance the method robustness of bioanalytical LC-MS/MS assay for a peptide drug. Bioanalysis, 13(6) : 429-441.
Szczygiel M,Muchowicz A,Demkow U .2021 .Development of a novel LC-MS/MS method for quantifying low-concentration impurities. Pharm Anal Acta, 12(5) : 534-541.
Kellner R,Mermet JM,Otto M,Widmer HM .2017 .Analytical Chemistry: A Modern Approach to Analytical Science. , : .
Bliesner DM .2017 .Validating Chromatographic Methods: A Practical Guide. , : .
Chatfield K,Donohoe D,Shen M,Harris G .2020 .Process analytical technology (PAT) tools and applications in pharmaceutical manufacturing. Pharm Technol Eur, 32(3) : 40-45.
Molnár I. .2018 .Computer-assisted development and optimization in HPLC using quality by design (QbD) principles. Trends Analyt Chem, 105 : 405-415.
Snyder LR,Kirkland JJ,Dolan JW .2019 .Introduction to Modern Liquid Chromatography. , : .
McDowell MT,Metters JP,Banks CE .2016 .Simplifying complex bioanalytical procedures through automated sample preparation. Talanta, 160 : 312-322.
Shen H,Kim DH,Xia C .2019 .Heller A. A new approach for automated high throughput screening using microplate spectrophotometers. Anal Chem, 91(8) : 4528-4535.
Fechner P,Pirkowska A,Wierzba D .2018 .Effect of process parameters on analytical method validation for related substances. J Pharm Biomed Anal, 154 : 127-136.
Witte P,Nehrenheim E,Friedel M. .2020 .The role of chemometrics in optimizing the sensitivity of bioanalytical assays for related substances. J Chromatogr A, 1601 : 10-18.
.2005 .Q9 Quality Risk Management. , : .
Miller JN,Miller JC .2020 .Statistics and Chemometrics for Analytical Chemistry. , : .
Kennerley BJ,Lea P,Barton J .2020 .Identifying key challenges in the detection of trace impurities. Anal Bioanal Chem, 412(5) : 2033-2042.
Tallam AK,Alapati S,Nuli MV . .RP-HPLC method for analytical method development and validation of multi-kinase inhibitor. Journal of Integral Sciences. 2023 Feb, 25 : 20-6.
Musumarra G,Barresi A,Sapuppo D .2021 .Stability-indicating methods in drug impurity profiling: Developments and regulatory guidelines. J Pharm Sci, 110(6) : 2056-2065.
Wenk M,Cook G,Hilton K. .2019 .Innovations in SFC method development for pharmaceutical applications. Anal Chem, 91(14) : 8963-8972.
Swartz M,Krull I. .2021 .Advances in Supercritical Fluid Chromatography for Pharmaceutical Analysis. , : .
Berendsen HH,Smit AB .2019 .Practical applications of LC-MS/MS in drug discovery and development. J Chromatogr B, 1107 : 88-101.
Xie Y,Qian M,Wang T,Chen W. .2018 .Method validation for trace-level impurity quantification in pharmaceuticals using UHPLC-MS/MS. , 159 : 139-148.
Vamsi Mohana,Nuli Mohana . .Analytical quality by design (AQbD) based optimization of RPUPLC method for determination of Nivolumab and Relatlimab in bulk and pharmaceutical dosage forms. Future Journal of Pharmaceutical Sciences. 2024 Jul, 10(1) : .
Rao V,Ramkrishna R,Kumar D. .2020 .Emerging approaches to impurity profiling and their significance in drug regulation. Int J Pharm Sci Rev Res, 63(1) : 14-22.
Krauss M,Hollender J,Singer H .2019 .Coupling of chromatography to mass spectrometry for impurity identification. Anal Chim Acta, 1097 : 80-91.
.2003 .Q1A(R2) Stability Testing of New Drug Substances and Products. , : .
Lough WJ,Wainer IW .2016 .Drug Stereochemistry: Analytical Methods and Pharmacology. , : .
Kim D,Ruzevich P,Kim J .2019 .Comprehensive impurity profiling and structural elucidation in pharmaceutical compounds. Biomed Chromatogr, 33(5) : .